Brammer Bio

250 Binney Street
Cambridge
Massachusetts
02142

Tel: 386-418-8199

Show jobs for this employer

About Brammer Bio


Brammer Bio offers clinical and commercial services to supply vectors for in vivo gene therapy and ex vivo modified-cell based therapy. This includes process and analytical development, and regulatory support, enabling large pharma and biotech clients to accelerate the delivery of novel medicines to improve patients' health. Brammer is owned by Ampersand Capital Partners, the only institutional investor in the company, and its founders.

YEAR FOUNDED:

2013

LEADERSHIP:

CEO: Mark Bamforth

CSO: Richard O. Snyder

CFO: Steven H. Kasok

JOBS:

Please click here for Brammer Bio job opportunities.

18 articles with Brammer Bio